Inactive Instrument

News Integrated BioPharma, Inc. Other OTC

Equities

INBP

US45811V1052

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 12	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 09	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-09-15	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-15	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-11	CI
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-21	AQ
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	23-03-21	CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	23-03-17	CI
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	23-02-10	AQ
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-10	CI
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	22-11-28	PU
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-11-28	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	22-11-10	AQ
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-10	CI
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	22-10-24	AQ
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)	22-09-13	AQ
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-13	CI
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)	22-07-15	AQ
Integrated BioPharma : Announces Change in Directors - Form 8-K	22-06-21	PU
INTEGRATED BIOPHARMA INC : Financial Statements and Exhibits (form 8-K)	22-06-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Integrated BioPharma, Inc. Other OTC

Equities

INBP

US45811V1052

Summary

Filters